Go Pro
Silvan Tuerkcan

Silvan Tuerkcan Analyst Performance

Senior Research Analyst at Citizens Jmp

Silvan Tuerkcan is a stock analyst at Citizens Jmp in the healthcare sector, covering 17 publicly traded companies. Over the past year, Silvan Tuerkcan has issued 21 stock ratings, including buy and hold recommendations. While full access to Silvan Tuerkcan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Silvan Tuerkcan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
64 Last 7 Years
Buy Recommendations
86.67% 52 Buy Ratings
Companies Covered
17 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy86.7%52 ratings
Hold13.3%8 ratings
Sell0.0%0 ratings

Out of 60 total stock ratings issued by Silvan Tuerkcan at Citizens Jmp, the majority (86.7%) have been Buy recommendations, followed by 13.3% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
88.2% of companies on NASDAQ
15 companies
NYSE
11.8% of companies on NYSE
2 companies

Silvan Tuerkcan, an analyst at Citizens Jmp, currently covers 17 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
17 companies
100.0%

Silvan Tuerkcan of Citizens Jmp specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
15 companies
88.2%
HEALTHCARE TECHNOLOGY
1 company
5.9%
PHARMACEUTICALS
1 company
5.9%

About Silvan Tuerkcan

Biophysicist; Equity research in biotechnology; Data scientist with expertise in ML and AI I am a equity research analyst of smid-cap biotechnology companies. We focus on pre-revenue companies that have differentiated assets that target unmet needs. I apply Bayesian statistics and other machine learning techniques to for automated decision making. I use a combination of statistics, model discrimination, and visualization techniques to extract relevant information. Beyond scientific data, I apply these techniques to help companies use their data in the fields of social media applications and drug discovery. My research interests lie in how small biological and statistical differences in different sub-populations within a cells can cause disease. My academic research focused on microscopy techniques, image analysis, and statistical methods to study the metabolism of cancer. My entrepreneurial interests lie in the field of digital health and biotechnology for clinical use.
Follow on LinkedIn

Silvan Tuerkcan's Ratings History at Citizens Jmp

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
6/23/2026Boost Price Target$6.53$11.00Market Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
3/26/2026Downgrade$52.86Hold
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
12/23/2025Reiterated Rating$57.91$86.00Market Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
12/11/2025Boost Price Target$44.61$57.00Market Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/26/2025Set Price Target$29.34$35.00
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
11/26/2025Boost Price Target$29.34$35.00Market Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
11/20/2025Boost Price Target$7.15$10.00Market Outperform
enGene Holdings Inc. stock logo
ENGN
enGene
11/12/2025Boost Price Target$9.27$21.00Market Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
11/7/2025Lower Price Target$12.32$21.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
11/5/2025Reiterated Rating$37.90$36.00Market Perform
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
11/5/2025Boost Price Target$4.27$8.00Market Outperform
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
11/4/2025Set Price Target$15.86$22.00
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
11/4/2025Boost Price Target$5.17$8.00Market Outperform
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
11/4/2025Boost Price Target$15.86$22.00Market Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/28/2025Lower Price Target$14.79$29.00Market Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
10/23/2025Lower Price Target$7.91$15.00Market Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
10/6/2025Upgrade$19.96$33.00Outperform
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
9/24/2025Reiterated Rating$13.22$20.00Market Outperform
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
9/22/2025Lower Price Target$2.51$6.00Market Outperform
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
9/19/2025Reiterated Rating$16.11Market Perform
Phreesia, Inc. stock logo
PHR
Phreesia
9/8/2025Boost Price Target$27.93$34.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
7/29/2025Reiterated Rating$37.59$50.00Market Outperform
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
7/8/2025Lower Price Target$3.19$12.00Market Outperform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
6/27/2025Reiterated Rating$46.70$86.00Market Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
6/25/2025Reiterated Rating$1.99$6.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
6/23/2025Boost Price Target$40.37$50.00Market Outperform
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
6/6/2025Reiterated Rating$4.57$15.00Market Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
6/2/2025Reiterated Rating$2.31$6.00Market Outperform
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
5/29/2025Boost Price Target$2.82$6.00Market Outperform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
5/21/2025Reiterated Rating$39.25$86.00Market Outperform
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
5/20/2025Lower Price Target$1.26$6.00Market Outperform
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
5/15/2025Reiterated Rating$4.18$9.00Market Outperform
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
5/15/2025Reiterated Rating$13.30$20.00Market Outperform
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
5/9/2025Reiterated Rating$2.76$120.00Market Perform
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
4/30/2025Reiterated Rating$4.16$9.00Market Outperform
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
4/28/2025Reiterated Rating$1.84$5.00Market Outperform
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
4/23/2025Initiated Coverage$4.24$9.00Market Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
4/23/2025Initiated Coverage$2.07$6.00Market Outperform
Terns Pharmaceuticals, Inc. stock logo
TERN
Terns Pharmaceuticals
4/21/2025Reiterated Rating$2.80$20.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
4/17/2025Reiterated Rating$36.30$41.00Market Outperform
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
4/10/2025Boost Price Target$11.64$20.00Market Outperform
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/13/2025Reiterated Rating$42.61$86.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
1/23/2025Reiterated Rating$32.70$41.00Market Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
1/15/2025Boost Price Target$36.78$41.00Market Outperform